s6y

Decoy Therapeutics Inc.

Ticker
DCOY
CIK
1615219
Industry
Pharmaceutical Preparations
Formerly
Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.

Financials 52

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K/A Annual Report for period ending Dec 31, 2025
  5. 10-K Annual Report for period ending Dec 31, 2025
  6. 10-Q Quarterly Report for period ending Sep 30, 2025
  7. 10-Q Quarterly Report for period ending Jun 30, 2025
  8. 10-Q Quarterly Report for period ending Mar 31, 2025
  9. 10-K Annual Report for period ending Dec 31, 2024
  10. 10-Q Quarterly Report for period ending Sep 30, 2024

All 52 financials filings

News 173

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 173 news filings

Ownership 321

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4 Statement of changes in beneficial ownership of securities

All 321 ownership filings

Prospectus 93

  1. S-3 Registration statement for specified transactions by certain issuers
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. S-1 General form of registration statement for all companies including face-amount certificate companies
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. S-1 General form of registration statement for all companies including face-amount certificate companies
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. RW Registration Withdrawal Request
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  10. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses

All 93 prospectus filings

Proxies 35

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  9. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  10. DEF 14A Definitive proxy statements

All 35 proxies filings

Other 72

  1. SCHEDULE 13G/A
  2. EFFECT Notice of Effectiveness
  3. SCHEDULE 13G
  4. EFFECT Notice of Effectiveness
  5. EFFECT Notice of Effectiveness
  6. SCHEDULE 13G/A
  7. SCHEDULE 13G
  8. SCHEDULE 13G
  9. SCHEDULE 13G
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 72 other filings